Today: 16 May 2026
Browse Category

Earnings Reports 8 January 2026

Standard Chartered stock edges up after buyback update; STAN.L investors eye Feb results

Standard Chartered stock edges up after buyback update; STAN.L investors eye Feb results

Standard Chartered shares rose 0.8% to 1,805 pence in early London trade after the bank bought back 537,006 shares, bringing total buyback spending to $1.11 billion. The buyback program, launched in August, is now about 86% complete and runs through Jan. 31. Full-year results are due Feb. 24. The bank also announced terms for three new bond issues under its $77.5 billion debt program.
Shell stock in focus after Q4 update flags chemicals loss and weaker trading

Shell stock in focus after Q4 update flags chemicals loss and weaker trading

Shell warned its Chemicals and Products segment will post adjusted earnings below break-even in Q4, citing weaker margins and lower trading. Shell’s ADRs closed down 1.9% in New York at $71.54; London shares fell 3.3% to £26.56. The company also flagged a $1.5 billion cash outflow for German emissions certificates. Investors await full results on Feb. 5.
Yangzijiang Shipbuilding (SGX:BS6) stock slips near 52-week high as traders eye March results

Yangzijiang Shipbuilding (SGX:BS6) stock slips near 52-week high as traders eye March results

Yangzijiang Shipbuilding shares fell 0.8% to S$3.61 in Singapore after touching a 52-week high. Phillip Securities Research called the stock a “technical buy” with S$3.48 as a stop-loss level. The company recently reported a 36.7% jump in half-year net profit and announced new contracts worth US$0.92 billion, but also terminated four tanker deals over sanctions concerns.
ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow shares closed up 1.4% at $150.90 Wednesday, marking a third straight gain despite lighter-than-average trading volume. The company will report fourth-quarter and full-year 2025 results after markets close on Jan. 28. Shares remain well below their 50- and 200-day moving averages. Investors await updates on the $7.75 billion Armis acquisition and subscription revenue outlook.
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher shares closed down 0.42% at $235.60 Wednesday, then edged up 0.16% after hours. CEO Rainer Blair will present at the J.P. Morgan Healthcare Conference Jan. 13, with Q4 earnings set for Jan. 28. Evercore ISI and TD Cowen raised price targets to $250 and $270, respectively. The stock traded between $233.26 and $238.00, with 2.7 million shares changing hands.
Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

A U.S. judge set Elon Musk’s lawsuit over OpenAI’s for-profit shift for a March jury trial, keeping Microsoft as a defendant. Microsoft shares closed up 1% at $483.47, valuing the company at about $3.85 trillion. Traders are watching Microsoft’s upcoming results for signals on Azure and AI spending. OpenAI reportedly set aside an employee stock pool worth 10% of the company, valued at $500 billion in October.
Verizon stock near $40: payrolls report, dividend date and Jan. 30 earnings in focus

Verizon stock near $40: payrolls report, dividend date and Jan. 30 earnings in focus

Verizon shares closed down 0.4% at $40.13 Wednesday, then edged to $40.15 after hours. The company will pay a 69-cent quarterly dividend on Feb. 2 to holders of record Jan. 12. Investors await Friday’s U.S. payrolls report and Verizon’s fourth-quarter results set for Jan. 30. A California hearing on the Frontier deal is also scheduled for Jan. 12.
AT&T stock dips again as downgrade and spectrum filings sharpen focus on Jan. 28 earnings

AT&T stock dips again as downgrade and spectrum filings sharpen focus on Jan. 28 earnings

AT&T shares fell 1.5% to $23.97 Wednesday after Arete Research cut the stock to sell and set a $20 target. The company announced new 5G connected-car deals with Mitsubishi and iM Media Labs at CES. AT&T is seeking more 3.45 GHz spectrum and plans to move its headquarters to Plano, Texas by late 2028. Investors await fourth-quarter results on Jan. 28, with analysts expecting 47 cents per share in earnings.
SoFi stock steadies after $1.6 billion share sale as BofA stays cautious ahead of earnings

SoFi stock steadies after $1.6 billion share sale as BofA stays cautious ahead of earnings

SoFi shares edged up 0.1% to $27 in after-hours trading Wednesday, staying below the recent $27.50 offering price. Underwriters exercised an option to buy extra shares, bringing the total sold to nearly 57.8 million. Bank of America resumed coverage at underperform, while Barclays raised its target to $28. Investors await SoFi’s Jan. 30 earnings report.
AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

AbbVie shares fell 1% to $231.11 in after-hours trading after the company denied reports of takeover talks with Revolution Medicines. A new SEC filing flagged a $1.3 billion fourth-quarter charge, prompting AbbVie to cut its 2025 adjusted earnings forecast to $9.90–$9.94 per share from $10.61–$10.65. Revolution shares dropped 11.5% late.
AppLovin stock rises after Feb. 11 earnings date set as Axon checks drive focus

AppLovin stock rises after Feb. 11 earnings date set as Axon checks drive focus

AppLovin shares rose about 2.5% to $632.92 in after-hours trading Wednesday after the company announced it will report fourth-quarter and full-year 2025 results on Feb. 11, following the U.S. market close. The stock traded between $611 and $643 during the session. CEO Adam Foroughi and CFO Matthew Stumpf will host a results webinar at 5 p.m. ET that day.
Walmart stock slips after hours even as KeyBanc lifts target — the next dates to watch

Walmart stock slips after hours even as KeyBanc lifts target — the next dates to watch

KeyBanc raised its price target on Walmart to $128, maintaining an Overweight rating, as Walmart shares fell 1.4% to $112.72 in after-hours trading. Albertsons cut its annual forecast, citing heavy discounting by Walmart and other rivals. Walmart’s last earnings showed U.S. comparable sales up 4.5% and e-commerce sales up 28%. The company will update investors at the ICR Conference on Jan. 13.
1 151 152 153 154 155 248

Stock Market Today

  • SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of IPO
    May 16, 2026, 1:24 AM EDT. SpaceX shareholders have approved a 5-for-1 stock split, Bloomberg News reported, following a recommendation by the company's board. The split will reduce the stock's fair market value per share from $526.59 to $105.32 and is expected to complete by May 22. SpaceX is preparing for an IPO as soon as June 12 on the Nasdaq, aiming to raise about $75 billion with a valuation near $1.75 trillion, potentially the largest U.S. stock market debut ever. The move positions the rocket and satellite maker for significant public market growth. SpaceX has not commented yet on the developments.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop